What Anthisan Treats: Main Uses and Benefits

---

The core therapeutic function of Anthisan cream is to provide supportive relief for symptoms related to localized irritative states on the skin. The cream is commonly used to help manage the symptomatic discomfort associated with exposure to various environmental irritants.

Anthisan is commonly used when symptoms appear suddenly or fluctuate following skin irritations, relevant in conditions presenting with acute episodes. The cream is used for conditions such as insect bites, stings (from wasps or bees), nettle rash, and to provide supportive relief for minor skin discomforts like mild sunburn or uncomplicated unbroken chilblains and superficial mild burns and scalds. Anthisan is relevant for easing symptom clusters that may become intense or disruptive, especially intense localized itching (pruritus), minor swelling, and accompanying redness and stinging pain.

Using the cream provides support that helps ease the overall symptom burden, contributing to improved comfort during these periods of heightened symptoms. The cream is relevant in contexts involving heightened systemic burden where additional symptomatic support is needed.

Quick Fact: Primary Therapeutic Domain
Used for managing symptoms related to inflammatory or irritative states and localized discomfort.

Regulatory References

1. Summary of Product Characteristics (SmPC) from the HPRA

Who Can and Cannot Use Anthisan?

The population eligibility for Anthisan Cream (Mepyramine Maleate 2%) is strictly defined by regulatory documents, distinguishing between permitted use, restrictions, and absolute contraindications.

---

Contraindicated Populations and Conditions

Official regulatory labeling dictates that Anthisan Cream must not be used in the following groups or conditions:

• Patients with known hypersensitivity to mepyramine maleate or any of the product’s excipients.
• Premature infants and neonates.
• Individuals with pre-existing skin conditions such as eczematous conditions or acute vesicular and exudative dermatoses.
• Application to broken skin surfaces, sunburnt skin, or when used with occlusive dressings.

---

Age and Physiological Restrictions

Category	Regulatory Status
Approved Age Group	Adults, the Elderly, and Children over 2 years of age are the permitted population.
Pediatric Restriction	Use is not recommended for children under 2 years old.
Pregnancy and Lactation	Should not be used during pregnancy or lactation, as safety has not been established, unless use is deemed essential by a healthcare professional.

---

Eligibility-Related Limitations

Regulatory documentation restricts the extent of application, stating that the cream must not be applied to large areas of the skin.

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Anthisan (Mepyramine Maleate 2% w/w topical cream) as being characterized by a general absence of documented interactions for this topical formulation.

Interaction scope

Property	Official Regulatory Statement
Medicinal product categories with documented interactions	None listed in the official interaction section of the Summary of Product Characteristics (SmPC).
Specific interacting medicines	None listed or formally classified as contraindicated combinations.
Mechanistic basis of interactions	None described, as the regulatory label does not specify pharmacokinetic (e.g., enzyme- or transporter-mediated) or pharmacodynamic bases for interactions.
Timing-based interaction rules	None specified for co-administered medicines.
Population-specific interaction notes	A caution exists regarding the theoretical risk of systemic effects (e.g., somnolence or mild disorientation) if the cream is applied over large areas of the skin, indicating a potential for increased systemic exposure in this usage context.
Interaction-related restrictions	No combination is formally classified as an interaction-based restriction in the label.

Interaction classifications (high-level)

Property	Official Regulatory Statement
Interaction severity classification	No significant interactions described in the official documents.
Regulatory basis	Summaries of Product Characteristics (SmPC) from national regulatory bodies.
Interaction-context constraints	The theoretical systemic effects are constrained to conditions where extensive absorption is possible.

Resulting interaction structure

Official interaction statements:

• Regulatory documents confirm the absence of formal drug-drug interactions for the topical cream.
• There are no specific interactions documented with food, alcohol, or herbal products.
• The only label-based interaction-related caution pertains to the potential for systemic absorption leading to central nervous system effects if the product is applied to very large areas of the skin.

Connection to the overall interaction profile (2–4 sentences):

The regulatory documentation formally defines the interaction structure of Anthisan as having no significant interactions described with other medicinal products. This statement explicitly excludes formal drug-drug, pharmacokinetic, or co-administration restrictions in the official labeling. The profile is characterized by the absence of formally documented concerns, with the only constraint being the population-specific caution related to potential systemic exposure under conditions of excessive topical application.

How Anthisan Works

H1 Receptor Antagonism

This drug functions as an antagonist by binding directly to the histamine H1 receptors located on peripheral cells, including those lining small blood vessels and peripheral sensory nerve endings. This targeted molecular action restricts the natural chemical histamine from accessing and activating the receptor. The resulting mechanism interrupts the downstream signaling cascade that is normally triggered by histamine binding.

---

Modifying Vascular and Neural Signaling

By preventing the activation of H1 receptors, the drug modifies the signaling dynamics of the local microvasculature and peripheral sensory nerve endings. This interruption of the cascade results in two core physiological consequences: a limitation of the histamine-driven increase in microvascular permeability and an attenuation of histamine-mediated sensory nerve firing. The mechanistic consequence is a modification of histamine-mediated local signaling.

How to Use Anthisan — Official Administration Guidelines

Anthisan (Mepyramine Maleate 2% w/w Cream) is administered topically—applied directly to the skin. The product requires no dilution or preparation before use.

Administration Scope

Property	Instruction/Principle
Route of administration	Topical (application directly to the skin).
Dosing schedule	Apply a very small amount of the 2% cream to the affected area.
Timing in relation to meals	Not applicable; topical administration.
Age-group administration rules	Approved for use in Adults, the elderly, and children over 2 years of age.
Special procedural conditions	Application should occur as soon as possible after the irritating event for best results.

---

Instruction Classifications (High-Level)

Classification	Principle
Administration method type	Topical application.
Frequency pattern	Multiple daily use, applied two to three times a day.
Use-context constraints	Use is strictly limited to a maximum duration of three days. Repeated application for periods longer than a few days is not recommended.

---

Resulting Procedural Structure

Official step sequence:

• Smooth a very small amount of the 2% cream directly onto the affected area of the skin.
• Repeat the application two or three times daily.
• Discontinue use if symptoms have not improved after three days.

Connection to the overall use protocol: The official administration protocol defines a localized and time-sensitive approach, requiring the topical delivery of a minimal amount of cream to the affected site at a set frequency of two to three times daily. This usage is constrained by a three-day maximum duration and is structurally intended as a short-term, intermittent method for adults and children over two years of age.

Research Evidence / Overview of Studies for Anthisan

Evidence for Symptomatic Relief of Acute Skin Reactions

Research exploring topical Mepyramine Maleate was evaluated in studies focused on conditions associated with acute or disruptive episodes, such as those caused by insect bites, stings, and nettle rash. Studies conducted during periods of increased symptom activity have examined patient-reported outcomes describing perceived discomfort, specifically the intensity of localized itching (pruritus), as well as physical signs like papules (localized swelling).

The overall evidence base includes small-scale Randomized Controlled Trials (RCTs) that have explored short-term symptom changes, often comparing the topical agent to a placebo or to other similar products. Studies reported measurements of outcomes related to physical discomfort during the observation period. Findings across the older body of research for the entire topical antihistamine class were mixed across different studies and contexts. The product's long history of use, alongside the general pharmacological understanding of the compound, contributes to the overall evidence landscape.

Research Limitations and Follow-up Duration

The available research primarily focused on episodes where symptoms become more noticeable, meaning the follow-up durations were limited to a short time frame, usually hours up to a few days. Long-term effects are not fully established because the product was studied for temporary, immediate symptomatic management. Data for certain groups, including older adults or those with pre-existing skin conditions, remain insufficient. The overall strength of the research evidence is broadly classified as limited or low to moderate, reflecting the nature of the studies that exist for this historical, over-the-counter agent.

Key Studies & References Summary of Product Characteristics for Anthisan Cream (Mepyramine Maleate 2% w/w) - HPRA

Common questions about Anthisan (FAQ)

Q: Is skin redness or increased itching at the application site a side effect of Anthisan?

A: Regulatory documentation states that an increase in skin redness, swelling, or itching in the treated area can occur. This is noted as a possible sign of a local hypersensitivity reaction or skin sensitization. The official patient information advises users to stop application if these types of reactions are noticed.

Q: Can using Anthisan cream make the skin more sensitive to sunlight?

A: The official safety profile indicates that increased sensitivity of the skin to sunlight, known as photosensitivity, is a possible side effect of the cream in the area of application. This means a stronger reaction may be experienced upon sun exposure in the treated area.

Q: Can Anthisan cause drowsiness if absorbed through the skin?

A: The official product information documents the potential for systemic side effects, such as drowsiness (somnolence) and mild disorientation. This risk is primarily associated with the theoretical absorption that may occur if the cream is applied to very large areas of the skin.

Q: Does Anthisan help relieve pain as well as itching and swelling?

A: Official regulatory documents indicate that the product is used for treating the pain, itching, and inflammation caused by insect stings and bites. The active ingredient is described as having both local analgesic (pain-relieving) and antipruritic (anti-itch) actions.

Q: Can Anthisan be used at the same time as taking oral antihistamine tablets?

A: Regulatory documents do not describe any significant interactions with other medicinal products. However, because the cream may be absorbed into the system, there is a theoretical caution regarding the possibility of additive effects on the central nervous system, which could potentially increase drowsiness.

Q: Does the cream interact with alcohol, even with topical use?

A: Official product information states that no specific interactions are documented with alcohol. The only related caution is the theoretical risk of systemic effects, such as drowsiness, which may occur if the cream is applied extensively.

Q: How quickly should Anthisan be applied after a bite or sting for best results?

A: Official directions recommend that for optimal response, application should occur as soon as possible after the bite or sting is sustained. Early application is described as essential for obtaining the optimum response.

Q: Are there specific warnings for elderly users of Anthisan?

A: Regulatory documents explicitly state that the cream is approved for use in the elderly population. The general caution concerning potential systemic side effects like drowsiness applies to all users if the cream is applied to large skin areas.

Q: Can Anthisan cream be used for mosquito bites specifically?

A: The product is officially indicated for the symptomatic relief of insect bites in general. As mosquito bites fall under the category of insect bites, the use of the cream is aligned with the general indication listed on the regulatory label.

Q: Is Anthisan suitable for stings from wasps or bees?

A: The product is officially indicated for the symptomatic relief of insect stings. Stings from insects such as wasps or bees are covered by the general insect sting indication listed in the official product documents.

Q: What types of rashes is Anthisan cream generally used for?

A: Regulatory documents consistently list the use of the cream for the symptomatic relief of nettle rash. Some official documentation also includes relief from irritation associated with allergic skin conditions.

Q: Is it appropriate to use Anthisan for unbroken chilblains?

A: Some regulatory documentation lists the use of the cream for the symptomatic relief of unbroken chilblains, in addition to its primary uses for insect stings, bites, and nettle rash.

Q: Does Anthisan stop the swelling or just the itching?

A: The cream is officially indicated for treating pain, itching, and inflammation. Its action is described as helping to ease the swelling and redness associated with localized skin irritation, in addition to its antipruritic (anti-itch) effect.

Q: Can Anthisan be used for a general skin irritation that isn't a bite?

A: The approved uses listed in regulatory documents are strictly limited to symptomatic relief for specific, defined conditions such as insect bites, stings, and nettle rash. The official label does not cover generalized skin irritation.

Q: Does Anthisan contain any numbing ingredients?

A: The active ingredient, Mepyramine Maleate, is described in regulatory pharmacology sections as having a local analgesic action in addition to its antihistamine and anti-itch properties. This means the ingredient carries properties associated with pain relief at the site of application.

Q: Are there any known long-term side effects from repeated use?

A: Regulatory directions emphasize that repeated use for periods longer than a few days is not recommended for this product. Due to the cream being studied for short-term, symptomatic use, long-term effects are not fully established.

Q: Does Anthisan cream contain parabens?

A: Official product information confirms that the cream contains methyl hydroxybenzoate as an excipient. This substance belongs to the paraben chemical family and is listed as an ingredient that may potentially cause an allergic reaction.

Q: Does having an underlying health condition like asthma affect using Anthisan?

A: Regulatory documentation does not list common systemic conditions such as asthma as a specific contraindication for the use of the topical cream. Contraindications are limited to certain skin conditions, age groups, and physiological states.

Q: Will covering the treated area with a bandage or dressing affect Anthisan?

A: Official regulatory documentation specifically states that the cream must not be applied under occlusive dressings, which include air-tight coverings or bandages. This restriction is in place because occlusive dressings may increase the risk of the cream being absorbed systemically.

Q: What ingredients in Anthisan could cause local skin reactions like contact dermatitis?

A: Regulatory information identifies excipients such as Ceto-stearyl alcohol, Castor oil, and Methyl hydroxybenzoate as ingredients that may cause local skin reactions or allergic reactions, including contact dermatitis.

Q: Can Anthisan be used to treat symptoms from a reaction to plants like poison ivy or oak?

A: The approved uses listed in regulatory documents are strictly limited to symptomatic relief for specific conditions such as insect bites, stings, and nettle rash. Plant reactions such as those from poison ivy or oak are not specifically covered by the official indication.

Q: Does Anthisan have any documented interaction with sunlight other than photosensitivity?

A: The only documented safety concern regarding sunlight in official documents is the potential for increased sensitivity of the skin, known as photosensitivity, in the area where the cream was applied.

Q: Is Anthisan cream a prescription-only medicine in any region?

A: The official regulatory status of the product varies by country. While it is classified as an Over-The-Counter or General Sale medicine in several regions, some regulatory bodies may classify it as a 'Pharmacy Only' medicine.

Q: Why is Anthisan cream not recommended for use on large areas of sunburnt skin?

A: The regulatory constraints combine two separate warnings: the cream should not be applied to sunburnt skin, and it should not be applied to large areas. Both warnings relate to the risk of increased systemic absorption, which could lead to potential systemic side effects like drowsiness.

Q: What is the role of the components like Ceto-stearyl alcohol and Castor oil in the cream?

A: Excipients such as Ceto-stearyl alcohol and Castor oil are inactive ingredients used in the creation of the cream base. Regulatory documents include a warning that these ingredients may cause local skin reactions, such as contact dermatitis.

Q: Is Anthisan cream still effective if it's past the expiry date?

A: Official directions state that the cream must not be used after the expiry date indicated on the carton or tube. This instruction ensures that the product is used within the time frame for which its stability and stated characteristics are maintained.

The storage and disposal of Anthisan (Mepyramine maleate) cream must strictly follow regulatory guidance to ensure stability and safety.

Storage Requirements

The cream must not be stored above 30°C and should be kept in a dry and dark place. To maintain its labeled shelf-life, the product should remain in its original container. A critical safety requirement is to keep the medicine out of the sight and reach of children.

Disposal Instructions

Any unused or expired Anthisan cream must be disposed of according to local regulations for pharmaceutical waste. While some labels state no special requirements exist after use, disposal should avoid flushing down toilets or placing in household waste, consistent with general medicinal waste procedures.